1Oktay R, Satar M, Atici A. The risk of bilirubin encephalopathy in neonatal hyperbilirubinemia. Turk Pediatr, 1996; 38(2): 199-204.
2Sarici SU, Serdar MA, Korkmaz A, et al. Incidence,course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics, 2004,113:775-780.
3Setia S, Villaveces A, Dhillon P, et al. Neonatal jaundice in Asian, White, and mixed-race infants. Arch Pediatr Adolesc Med, 2002, 156(3) :276-279.
4Patra K, Storfer-Isser A, Siner B, et al. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr, 2004,144(5) :626-631.
5Duman N, Ozkan H, Serbetcionglu B, et al. Long-term follow-up of otherwise healthy term infants with marked hyperbilirubinaemia: should the limits of exchange transfusion be changed in Turkey? Acta Paediatr, 2004, 93(3) :361-367.
6Seidman DS, Moise J, Ergaz Z, et al. A prospective randomized controlled study of phototherapy using blue and blue-green light-emitting devices, and conventional halogen-quartz phototherapy. J Perinatol, 2003, 3 ( 2 ) :123-127.
7Chang YS, Hwang JH, Kwon HN, et al. In vitro and in vivo efficacy of new blue light emitting diode phototherapy compared to conventional halogen quartz phototherapy for neonatal jaundice. J Korean Med Sci, 2005, 20 ( 1 ) :61-64.
8Chen CM, Liu SH, Lai CC, et al. Changing position does not improve the efficacy of conventional phototherapy. Acta Pediatr Taiwan, 2002,43 ( 5 ) : 255-258.
9Nuntnarumit P, Naka C. Comparison of the effectiveness between the adapted-double phototherapy versus conventional-single phototherapy. J Med Assoc Thai, 2002,85 Suppl 4 : S1159-S1166.
10Maisels M J, Kring E. Rebound in serum bilirubin level following intensive phototherapy. Arch Pediatr Adolesc Med, 2002,156(7) :669-672.
